Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Perspectives for therapy of treatment‐resistant depression
Mariusz Papp, Wiesław Jerzy Cubała, Łukasz Świȩcicki, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 17, pp. 4181-4200
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study)
Giovanni Martinotti, Antonio Vita, Andrea Fagiolini, et al.
Journal of Affective Disorders (2022) Vol. 319, pp. 646-654
Closed Access | Times Cited: 71
Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile
Jenessa N. Johnston, Maximillian Greenwald, Ioline D. Henter, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 4, pp. 103518-103518
Open Access | Times Cited: 31
Early Life Stress and Major Depressive Disorder—An Update on Molecular Mechanisms and Synaptic Impairments
Amanda Gollo Bertollo, Agatha Carina Leite Galvan, Claudia Dallagnol, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6469-6483
Closed Access | Times Cited: 7
Bifidobacteria with indole-3-lactic acid-producing capacity exhibit psychobiotic potential via reducing neuroinflammation
Xin Qian, Qing Li, Huiyue Zhu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 11, pp. 101798-101798
Open Access | Times Cited: 7
Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders
Adrian Newman‐Tancredi, Ronan Depoortère, Mark S. Kleven, et al.
Pharmacology & Therapeutics (2021) Vol. 229, pp. 107937-107937
Closed Access | Times Cited: 54
Dextromethorphan/Bupropion: A Novel Treatment for Patients With Major Depressive Disorder
Kristine C. Willett, LeDea R. Bond, Amanda M. Morrill, et al.
American Journal of Therapeutics (2024) Vol. 31, Iss. 1, pp. e24-e29
Closed Access | Times Cited: 6
Low-carbohydrate diet as a nutritional intervention in a major depression disorder: focus on relapse prevention
Michał Walaszek, Zofia Kachlik, Wiesław Jerzy Cubała
Nutritional Neuroscience (2024), pp. 1-14
Closed Access | Times Cited: 6
Single arketamine in treatment resistant depression: Presentation of 3 cases with regard to sick-leave duration
Adam Włodarczyk, Jakub Słupski, Joanna Szarmach, et al.
Asian Journal of Psychiatry (2024) Vol. 96, pp. 104016-104016
Open Access | Times Cited: 6
Molecular mechanism of Chang Shen Hua volatile oil modulating brain cAMP-PKA-CREB pathway to improve depression-like behavior in rats
Shuangli Zhang, Yilong Hu, Yinan Zhao, et al.
Phytomedicine (2024) Vol. 130, pp. 155729-155729
Closed Access | Times Cited: 6
Residual Fatigue in Unipolar and Bipolar Depression: A Systematic Review
Michał Pastuszak, Wiesław Jerzy Cubała, Katarzyna Jakuszkowiak‐Wojten, et al.
Neuropsychopharmacology Reports (2025) Vol. 45, Iss. 1
Open Access
Alterations in temporal-spatial brain entropy in treatment-resistant depression treated with nitrous oxide: Evidence from resting-state EEG
Weizhuang Kong, Zhe Sun, Jing Zhu, et al.
Clinical Neurophysiology (2025) Vol. 171, pp. 182-191
Closed Access
Eficácia da cetamina e esketamina no tratamento da depressão: revisão das evidências e perspectivas futuras
RAPHAELA NOGUEIRA DUTRA, Mario Vitor Ferreira Nascimento, João Pedro Silva Gontijo, et al.
STUDIES IN HEALTH SCIENCES (2025) Vol. 6, Iss. 1, pp. e14206-e14206
Closed Access
The Role of Gasotransmitter-Dependent Signaling Mechanisms in Apoptotic Cell Death in Cardiovascular, Rheumatic, Kidney, and Neurodegenerative Diseases and Mental Disorders
Stanislav Rodkin, Chizaram Nwosu, Alexander Sannikov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6014-6014
Open Access | Times Cited: 15
Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
Maria Gałuszko‐Węgielnik, Zuzanna Chmielewska, Katarzyna Jakuszkowiak‐Wojten, et al.
Brain Sciences (2023) Vol. 13, Iss. 1, pp. 142-142
Open Access | Times Cited: 13
Engeletin alleviates depression‐like phenotype by increasing synaptic plasticity via the BDNF‐TrkB‐mTORC1 signalling pathway
Yangyang Xu, Jie Zhang, Linyao Yu, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 23, pp. 3928-3938
Open Access | Times Cited: 13
Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review
Aleksander Kwaśny, Julia Kwaśna, Alina Wilkowska, et al.
European Neuropsychopharmacology (2024) Vol. 86, pp. 20-34
Closed Access | Times Cited: 4
Tas2r123-associated mitochondrial organization and neuroplasticity underlying the antidepressant effect of resveratrol
Hailong Ge, Lujia Si, Chen Li, et al.
Brain Research Bulletin (2025) Vol. 223, pp. 111271-111271
Open Access
Stereotactic Radiosurgery for Treatment Resistant Depression: Systematic Review
Jordan Vanleuven, Yusuke Hori, T. Osama, et al.
World Neurosurgery X (2025), pp. 100451-100451
Open Access
Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
Aleksander Kwaśny, Adam Włodarczyk, Damian Ogonowski, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 568-568
Open Access | Times Cited: 11
Altered blood parameters in “major depression” patients receiving repetitive transcranial magnetic stimulation (rTMS) therapy: a randomized case-control study
Beyza Nur Özkan, Kübra Bozalı, Muhammed Emin Boylu, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Fusing features of speech for depression classification based on higher-order spectral analysis
Miao Xiao-lin, Yao Li, Min Wen, et al.
Speech Communication (2022) Vol. 143, pp. 46-56
Open Access | Times Cited: 16
Residual insomnia in major depressive disorder: a systematic review
Aleksander Kwaśny, Adam Włodarczyk, Alicja Dywel, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
Anhedonia and depression severity measures during ketamine administration in treatment-resistant depression
Aleksander Kwaśny, Wiesław Jerzy Cubała, Adam Włodarczyk
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Overcoming treatment gaps in the management of depression with non-pharmacological adjunctive strategies
György Purebl, Katharina M. Schnitzspahn, Éva Zsák
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 8
Antidepressant-like effect of tofisopam in mice: A behavioural, molecular docking and MD simulation study
Nazlı Turan Yücel, Asaf Evrim Evren, Ümmühan Kandemir, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 7, pp. 819-835
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top